FBLG vs. AMRN, RVNC, ORGO, ANRO, ACIU, TERN, NBTX, PGEN, KRRO, and VRCA
Should you be buying FibroBiologics stock or one of its competitors? The main competitors of FibroBiologics include Amarin (AMRN), Revance Therapeutics (RVNC), Organogenesis (ORGO), Alto Neuroscience (ANRO), AC Immune (ACIU), Terns Pharmaceuticals (TERN), Nanobiotix (NBTX), Precigen (PGEN), Korro Bio (KRRO), and Verrica Pharmaceuticals (VRCA). These companies are all part of the "pharmaceutical preparations" industry.
FibroBiologics (NASDAQ:FBLG) and Amarin (NASDAQ:AMRN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, community ranking, profitability, institutional ownership, valuation and earnings.
Amarin received 842 more outperform votes than FibroBiologics when rated by MarketBeat users.
22.3% of Amarin shares are owned by institutional investors. 2.0% of Amarin shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, FibroBiologics had 4 more articles in the media than Amarin. MarketBeat recorded 4 mentions for FibroBiologics and 0 mentions for Amarin. Amarin's average media sentiment score of 0.36 beat FibroBiologics' score of 0.34 indicating that Amarin is being referred to more favorably in the news media.
Amarin has a consensus price target of $1.08, indicating a potential upside of 24.52%. Given Amarin's higher probable upside, analysts clearly believe Amarin is more favorable than FibroBiologics.
FibroBiologics has higher earnings, but lower revenue than Amarin.
FibroBiologics has a net margin of 0.00% compared to Amarin's net margin of -18.96%. FibroBiologics' return on equity of 0.00% beat Amarin's return on equity.
Summary
Amarin beats FibroBiologics on 7 of the 12 factors compared between the two stocks.
Get FibroBiologics News Delivered to You Automatically
Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
FibroBiologics Competitors List
Related Companies and Tools
